Recombinant Human IL2RA Protein
Cat.No. : | IL2RA-5198H |
Product Overview : | Human IL2RA (P01589, Glu 22 - Cys 213) partial recombinant protein expressed in HEK293 cells. |
- Specification
- Gene Information
- Related Products
Description : | The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. [provided by RefSeq |
Source : | HEK293 |
Species : | Human |
Form : | Lyophilized |
Molecular Mass : | 44 kDa |
Endotoxin : | < 0.1 ng/μg (1 EU/μg) |
Purity : | > 90% by SDS-PAGE and HPLC |
Applications : | SDS-PAGE |
Storage : | Store at 4 centigrade. For long term storage store at -20 centigrade or -80 centigrade. Aliquot to avoid repeated freezing and thawing. |
Storage Buffer : | Lyophilized from PBS, pH 7.2 |
Gene Name : | IL2RA interleukin 2 receptor, alpha [ Homo sapiens ] |
Official Symbol : | IL2RA |
Synonyms : | IL2RA; interleukin 2 receptor, alpha; IL2R; interleukin-2 receptor subunit alpha; CD25; p55; IL2-RA; IL-2-RA; TAC antigen; IL-2R subunit alpha; IL-2 receptor subunit alpha; TCGFR; IDDM10; |
Gene ID : | 3559 |
mRNA Refseq : | NM_000417 |
Protein Refseq : | NP_000408 |
MIM : | 147730 |
UniProt ID : | P01589 |
Products Types
◆ Recombinant Protein | ||
Il2ra-1676M | Recombinant Mouse Il2ra Protein, His-tagged | +Inquiry |
IL2RA-942R | Recombinant Rat IL2RA Protein (Met1-Gln235), His-tagged | +Inquiry |
Il2ra-5704M | Active Recombinant Mouse Il2ra protein(Met1-Lys236), hFc-tagged | +Inquiry |
IL2RA-319H | Recombinant Human IL2RA Protein, His-tagged | +Inquiry |
Il2ra-1677M | Recombinant Mouse Il2ra Protein, His-tagged | +Inquiry |
◆ Lysates | ||
IL2RA-1015CCL | Recombinant Cynomolgus IL2RA cell lysate | +Inquiry |
IL2RA-2907HCL | Recombinant Human IL2RA cell lysate | +Inquiry |
IL2RA-2024MCL | Recombinant Mouse IL2RA cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThe combination of IL2RA and other drugs may produce nausea, vomiting, rash and other adverse reactions, should be monitored.
The frequency of use of IL2RA depends on the specific situation of the patient, and is generally used 1-3 times per week.
IL2RA, in the right dosage and frequency of use, can significantly relieve symptoms of diseases such as autoimmune diseases and organ transplant rejection.
Can assist in the treatment of some types of malignant tumors, but it is not a complete cure for cancer.
The effective rate of IL2RA therapy depends on many factors such as the type of disease, the patient's condition and the treatment regimen, and the effective rate is generally between 50% and 90%.
Indications of IL2RA include a variety of autoimmune diseases, organ transplant rejection and malignant tumors.
Customer Reviews (3)
Write a reviewSecurity is very high and can be used with confidence.
Structure is very stable and not prone to mutation.
The amount of expression is very high and can be easily detected.
Ask a Question for All IL2RA Products
Required fields are marked with *
My Review for All IL2RA Products
Required fields are marked with *
Inquiry Basket